Cellectis (CLLS) Misses Q2 EPS by 29c

Cellectis (NASDAQ: CLLS) reported Q2 EPS of ($0.80), $0.29 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $14.62 million versus the consensus estimate of $23.46 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Piper Sandler on FirstSun Capital Bancorp (FSUN): 'We expect shares to underperform on Friday'
• Barclays upgrades CubeSmart, cuts Public Storage on relative valuation